Advertisement

PentaVision

Eyecare Business

Article

Building the Myopia Toolbox

The myopia management landscape in the United States may be developing more slowly than other global markets, but the first wave of FDA-approved technologies is shaping the standard of care and redefining how practitioners approach progressive myopia.

By: Veronica Daub
Eyecare Business June 30, 2026
5 Key Takeaways

  • 1

    The myopia management landscape in the US is evolving, with FDA-approved technologies shaping treatment options for progressive myopia.

  • 2

    CooperVision MiSight 1 day is the first FDA-approved soft contact lens designed to slow myopia progression in children aged 8 to 12.

  • 3

    Essilor Stellest, approved by the FDA in 2025, is a spectacle lens that combines vision correction with myopia management for children aged 6 to 12.

  • 4

    Johnson & Johnson Vision's Acuvue Abiliti Overnight lenses are FDA-approved orthokeratology lenses that reshape the cornea to manage myopia progression.

  • 5

    Notable myopia management products like Hoya's MiyoSmart and Zeiss MyoCare are not currently available to US eyecare professionals and patients.